Stockreport

HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up [Yahoo! Finance]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF The acquisition offer implied a fully diluted equity value of €2.0 billion. Halozyme decided to withdraw the acquisition bid following the unwillingness of Evotec's ma [Read more]